Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Alfa Chemistry Launches MOF Chemicals for the Science Community

    Jan 27, 2021, 14:54 PM by
    As the fastest growing class of materials in chemistry today, metal-organic frameworks (MOFs) have become ideal candidates for storage of fuels (hydrogen and methane), capture of carbon dioxide, and catalysis applications as well as many other applications. To meet the increasing market demand accompanying this trend, Alfa Chemistry has recently launched a subsidiary website, which is specially designed for supplying MOF chemicals, COFs linkers, and MOF materials.
    Full story
  • Prime Global and Raremark form strategic partnership to transform solutions and outcomes for patients with rare diseases

    Jan 27, 2021, 14:54 PM by
    Medical communications company, Prime Global, and healthcare technology company, Raremark®, announced today that they have formed a strategic partnership to transform solutions for patients with rare diseases. Together, the companies will uncover insights into the entire patient journey that will allow the creation of truly patient-centric drug development and commercialisation programs. Focusing on the needs of patients is the key to powerful communications that make a tangible difference to patient outcomes.
    Full story
  • CluePoints’ Risk-Based Quality Management Platform Instrumental in Data Quality Oversight of COVID-19 Trials

    Jan 27, 2021, 14:54 PM by
    CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced that its Risk-Based Quality Management (RBQM) platform has been critical in supporting numerous Pharmaceutical companies and CROs to interrogate data in their global COVID-19 vaccine and antiviral antibody trials to ensure data quality and integrity.
    Full story
  • Domainex expands executive team to support ongoing growth

    Jan 27, 2021, 14:54 PM by
    Domainex welcomes David Cronk to the team as its new Chief of Staff and promotes long standing team member and previous Head of Chemistry, Dr Ray Boffey, to Executive Director of Medicines Research.
    Full story
  • PhenoTips® launches Pre-Visit Patient Questionnaires that automatically generate pedigrees using patient-entered data

    Jan 27, 2021, 14:54 PM by
    PhenoTips, creator of the world’s first complete Genomic Health Record™, has launched a digital tool that automatically generates pedigrees from patient-entered information. Pre-Visit Patient Questionnaires are delivered virtually to patients, building pedigrees and patient records in advance of a patient’s initial consultation, which improves the appointment efficiency by over 50% due to the elimination of manual data entry.
    Full story
  • Bally Ribbon Mills Manufacturing Materials to Ensure Health and Safety of Front-Line Workers

    Jan 27, 2021, 14:54 PM by
    The press release announces Bally Ribbon Mills continues to focus on producing its line of narrow woven structural tapes and elastics, as well as safety webbing, to protect front-line workers responding to the current global health crisis.
    Full story
  • Alfa Chemistry Recently Launched a Sub-website for Functional Polymers

    Jan 27, 2021, 14:54 PM by
    Alfa Chemistry announced the launch of a new sub-website for the supply of functional polymers, including Adsorptive Polymers, Biomedical Polymers, Electrofunctional Polymers, Functional PEGs, Photoactive Polymers, Silicone Polymers and more.
    Full story
  • CD BioSciences Reveals Its Capabilities in Conducting Proof of Concept Research

    Jan 27, 2021, 14:54 PM by
    CD BioSciences, a professional US provider of integrated solutions for clinical trials development, has revealed its capabilities of conducting Proof of Concept (PoC) studies and pivotal clinical research for drug development scientists in biological and pharmaceutical institutes and companies.
    Full story
  • Alfa Chemistry Announced to Supply Derivatization Reagents for Analytical Testing Scenarios

    Jan 27, 2021, 14:54 PM by
    Earlier this month, Alfa Chemistry announces in a recent statement that the company is starting to provide derivatization reagents of all kinds for customers across the globe. With all the previously released products added together, now the company offers analytical reagents, analytical standards, chromatography standards, and derivatization reagents. In the near future, Alfa Chemistry will continue to add more reagents to meet the increasing demand arising from analytical testing scenarios.
    Full story
  • MedAI Launches Artificial Intelligence Drug Discovery (AIDD) Platform to Accelerate Drug Development

    Jan 27, 2021, 14:54 PM by
    To accelerate drug development, MedAI, an expert of AI-assisted R&D research company, announces that it has completed the construction of its Artificial Intelligence Drug Discovery (AIDD) Platform. With this platform, scientists at MedAI are now capable of providing innovative solutions for pharmaceutical companies to push forward their drug discovery projects.
    Full story
  • Solentim sets new standards in productivity with the launch of ICON™ and STUDIUS™; accelerating assurance rich workflows in the development of new biologics

    Jan 27, 2021, 14:54 PM by
    Solentim launches two new solutions to enhance the development of therapeutic antibodies. ICON™ is a benchtop system for the rapid stratification of high productivity clones and STUDIUS™ is a proprietary software platform that delivers unparalleled data on each cell’s journey through cell line development.
    Full story
  • Parent Project Muscular Dystrophy’s Duchenne Registry Participant Response Rate Increases Exponentially in 2020 Utilizing THREAD

    Jan 27, 2021, 14:54 PM by
    Year one of The Duchenne Registry powered by THREAD’s decentralized platform sees uptick in survey completion, data collection, and community engagement.
    Full story
  • Certa Sine pump makes transporting high-viscosity 3D printing materials easy

    Jan 27, 2021, 14:54 PM by
    Innovative German dental materials manufacturer relies on Certa pump technology to transport high-viscosity 3D printing materials.
    Full story
  • Thermo Fisher Scientific Releases SARS-CoV-2 Optimized Precipitation Reagent* and Enrichment Kits* for Isolating Virus Particles

    Jan 27, 2021, 14:54 PM by
    Full story
  • Vaccine Pods Launches from Stealth to Help Eradicate COVID and Announces Collaboration with Stirling Ultracold for its Vaccine Freezers

    Jan 27, 2021, 14:54 PM by
    Vaccine Pods’ industry-first technology, powered by HCI Energy, boosts capacity and power for ultra-low temperature cold chain storage, enabling organizations to safely store and deliver COVID vaccines
    Full story
  • Promise of ISR Inhibitors In Treating Age-Related Cognitive Decline

    Jan 27, 2021, 14:26 PM by User Not Found
    Bio-IT World | An intracellular signaling network known as the integrated stress response (ISR) is of growing interest to drug developers because it seems to be affecting so many clinical conditions, ranging from Down syndrome and traumatic brain injury (TBI) to hearing loss, some types of prostate cancer, and the natural process of aging, according to Susanna Rosi, Ph.D., director of neurocognitive research in the UCSF Brain and Spinal Injury Center.
    Full story
  • At Least Five Disease Variants, Pandemic Impact on Life Span, Role of Past Coronavirus Infection on Immunity: COVID-19 Updates

    Jan 22, 2021, 10:12 AM by User Not Found
    Bio-IT World | A modeling platform validated in New York predicts the spread of COVID-19 in small towns and cities, Americans have lost more than a year of life expectancy, the role of antibodies from previous infections, and wastewater sequencing to track SARS-CoV-2 variants. Plus: new modeling tools to prioritize vaccine distribution and more efforts on drug repositioning.
    Full story
  • Deep Longevity Building An Arsenal of Aging Clocks

    Jan 21, 2021, 14:29 PM by User Not Found
    Bio-IT World | In the not-too-distant future, people could be paying a monthly fee to access a long list of “aging clocks” serving as bellwethers of their health and efforts to improve their physical condition. Physicians might also be procuring medical-grade reports on the aging process of their patients. It is a business model Hong Kong startup Deep Longevity is banking on.
    Full story
  • Smart Data Management in the Race toward Effective Vaccines

    Jan 20, 2021, 01:00 AM by User Not Found
    Bio-IT World | As vaccines for the novel coronavirus are starting to be rolled out across the world, all eyes are on the scientific community. Demand for novel therapeutics is higher today than ever before and will continue to be in the future. Whether you’re a contract development and manufacturing organization (CDMO) or a vaccine manufacturer, smart data strategy is critical
    Full story
  • Domainex invests in the Creoptix WAVEdelta to strengthen its fragment-based drug discovery platform

    Jan 19, 2021, 11:34 AM by
    Domainex Ltd. has invested in the WAVEdelta instrument from Creoptix AG. This instrument utilizes Grating-Coupled Interferometry to measure target binding and achieves superior resolution to traditional Surface Plasmon Resonance.
    Full story
  • «
  • 181
  • 182
  • 183
  • 184
  • 185
  • 186
  • 187 (current)
  • 188
  • 189
  • 190
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy